Category Specific RSS

infant formula

Bubs enrols 400th infant in its US clinical trials to get baby formula approval

Under its old business model, the number 4 would typically never be marketed to their major customers but under the…

1 year ago

Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits

In 2023, global birth rates dipped by 1.15% per 1000 people, with significant declines noted in the EU (5.9%) and…

2 years ago

Bubs presents its rebound plan after bitter breakup with former CEO and Chairman

A bitter boardroom spat has left baby formula company Bubs Australia (ASX: BUB) scrambling to undertake serious damage control following…

2 years ago

Synlait receives permit renewal to supply baby formula to the Chinese market

China has emerged as a hotspot for baby formula export from Australia and New Zealand. Imported baby formula holds a…

2 years ago

Bubs Australia founder and CEO forced out for alleged failure to comply with board directions

Just a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business,…

2 years ago

China revenue falls 66% as Bubs reports declining sales

The infant formula market has more than doubled over the past decade. But not all companies have managed to keep…

3 years ago